Currently, there are 83.93M common shares owned by the public and among those 81.92M shares have been available to trade.
The company’s stock has a 5-day price change of -0.64% and -19.17% over the past three months. ADNT shares are trading -18.98% year to date (YTD), with the 12-month market performance down to -58.66% lower. It has a 12-month low price of $13.34 and touched a high of $33.74 over the same period. ADNT has an average intraday trading volume of 1.35 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -5.08%, -13.84%, and -31.61% respectively.
Institutional ownership of Adient plc (NYSE: ADNT) shares accounts for 100.58% of the company’s 83.93M shares outstanding.
It has a market capitalization of $1.17B and a beta (3y monthly) value of 1.95. The stock’s trailing 12-month PE ratio is 889.17, while the earnings-per-share (ttm) stands at $0.02. The company has a PEG of 38.96 and a Quick Ratio of 0.86 with the debt-to-equity ratio at 1.40. Price movements for the stock have been influenced by the stock’s volatility, which stands at 4.59% over the week and 5.01% over the month.
Earnings per share for the fiscal year are expected to decrease by -6.41%, and 50.99% over the next financial year.
Looking at the support for the ADNT, a number of firms have released research notes about the stock. BofA Securities stated their Underperform rating for the stock in a research note on March 04, 2025, with the firm’s price target at $24-$18. Wells Fargo coverage for the Adient plc (ADNT) stock in a research note released on December 16, 2024 offered a Equal Weight rating with a price target of $20. BofA Securities was of a view on November 21, 2024 that the stock is Neutral, while Deutsche Bank gave the stock Hold rating on September 10, 2024, issuing a price target of $24. Wolfe Research on their part issued Peer Perform rating on September 05, 2024.
